Dyc Co.,Ltd. (KOSDAQ:310870)
South Korea · Delayed Price · Currency is KRW 1,658.00
-85.00 (-4.88%)
At close: Aug 1, 2025, 3:30 PM KST
Achilles Therapeutics Revenue
Dyc Co.,Ltd. had revenue of 26.08B KRW in the quarter ending March 31, 2025, a decrease of -6.84%. This brings the company's revenue in the last twelve months to 98.20B, down -16.96% year-over-year. In the year 2024, Dyc Co.,Ltd. had annual revenue of 100.11B, down -18.22%.
Revenue (ttm)
98.20B
Revenue Growth
-16.96%
P/S Ratio
0.34
Revenue / Employee
554.79M
Employees
177
Market Cap
33.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 100.11B | -22.31B | -18.22% |
| Dec 31, 2023 | 122.42B | 1.77B | 1.46% |
| Dec 31, 2022 | 120.65B | 33.38B | 38.25% |
| Dec 31, 2021 | 87.27B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition